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journal homepage: www.j fda-onl ine.comEditorialForewordGlobal challenges call for global strategies. This simple notion
was the driving force behind the “Conference to Promote
Global Health” convened in Taipei, in April 2013. Its ambitious
goals were to build research capacity, stimulate transnational
collaborations in the Asian and Pacific Islander (API) region,
and advance scientific knowledge that would address critical
issues related to substance abuse and human immunodefi-
ciency virus (HIV) infection, two intertwined health threats
that are rising in many Asian countries.
Drug abuse and addiction have being fueling the global
spread of HIV from the very beginning of the AIDS epidemic.
Drugs are still partly responsible for an unacceptably high
number of new HIV infections (nearly 50,000/year in the
United States alone). This inextricable connection is predi-
cated on at least three major public health challenges: (1) the
direct effects of contaminated injection drug use on infection
rates; (2) the indirect impact of abused drugs on high-risk sex
behavior and treatment adherence; and (3) the ability of drugs
to worsen the neurologic complications stemming from an
HIV infection.
On the positive side, exciting discoveries have recently
shown that HIV prevention among drug users (which includes
HIV treatment) is effective in reducing HIV prevalence and
that treating substance use disorders (particularly with the
aid of new and more effective medications) improves HIV
treatment outcomes. A broad consensus was evident among
the attendees that such findings should be parlayed into
global instruments against the HIV epidemic as quickly as
possible. One promising instrument that is worth highlighting
in this context, referred to as the Seek, Test, Treat, and Retain
(STTR) paradigm, seeks out hard-to-reach/high-risk pop-
ulations, including substance abusers and those in the crim-
inal justice system, tests them for HIV, links those who test
positive to HIV treatment and other services, and provides the
necessary support to ensure these individuals remain in the
care system.In addition, the scientists attending the meeting zeroed
in on several additional key research topics, a global commit-
ment towhich is bound tomake a real difference in the lives of
millions of people. These topics include: (1) the neuroscience
of HIV/hepatitis C virus (HCV) and amphetamine-type stimu-
lants (ATS); (2) the links between ATS abuse andmental health
disorders; (3) studies of HIV/HCV transmission and social
networks; and (4) approaches to enhance family involvement
to improve treatment adherence and recovery. To carry out
this far-reaching agenda, it was agreed at this meeting that
several workgroups will be established to stimulate cross-
national collaborations geared towards improving our scien-
tific understanding vis-a´-vis all the topics identified and,
ultimately, boosting clinical outcomes.
An intense and decades-long scientific effort has turned
HIV into a manageable chronic disease, but benefits have
lagged behind for infected substance abusers. However,
recent findings on the feasibility of treating substance abusers
with HIV both with antiretroviral and substance abuse treat-
ment have shown that this improves their outcomes and re-
duces the spread of the disease. The increasing recognition
that the treatment of HIV in substance abusers is crucial for
containing the HIV epidemic globally represents a huge step
forward. The Conference to Promote Global Health has now
charted a credible strategy for facilitating the implementation
of these advances.
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